Viewing StudyNCT00215956



Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00215956
Status: COMPLETED
Last Update Posted: 2013-12-23
First Post: 2005-09-19

Brief Title: A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma
Sponsor: H Lee Moffitt Cancer Center and Research Institute
Organization: H Lee Moffitt Cancer Center and Research Institute

Organization Data

Organization: H Lee Moffitt Cancer Center and Research Institute
Class: OTHER
Study ID: MCC-12349
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: H Lee Moffitt Cancer Center and Research Institute
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
GlaxoSmithKline INDUSTRY